Healthcare Technology
News Category
Vinmec Launches Vietnam's First Integrated High-Tech Robotic Surgery Network
Vinmec Healthcare System has launched Vietnam's first integrated multi-connected robotic surgery ecosystem, deploying advanced robotic platforms acros...
HeartBeam Restructures to Accelerate Global Commercialization of Cardiac Monitoring Platform
HeartBeam (NASDAQ: BEAT) announced a strategic reorganization to streamline operations, reduce costs, and accelerate global commercialization of its p...
HeartBeam Launches Pilot Study of On-Demand 12-Lead ECG Patch for Ischemia Detection
HeartBeam announced a pilot study evaluating its proprietary patch that can generate on-demand 12-lead ECGs to detect ischemia, potentially disrupting...
Accelerometer Medical Sensors Market to Reach USD 25.7 Billion by 2036 as Remote Monitoring and Wearable Healthcare Technologies Accelerate Adoption
The global accelerometer medical sensors market is projected to grow from USD 7.0 billion in 2026 to USD 25.7 billion by 2036, driven by increased ado...
Smartphone Apps and Wearable Trackers Boost Physical Activity in Heart Disease Patients
A meta-analysis of 14 clinical trials found that people with cardiovascular disease using smartphone apps and fitness trackers walked nearly 1,100 mor...
SS Innovations Completes World-Record 12,500-Mile Robotic Cardiac Telesurgery
SS Innovations International successfully performed the world's longest-distance robotic cardiac telesurgery over 12,500 miles, demonstrating the capa...
HeartBeam Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
A study published in JACC: Advances found that a risk prediction algorithm using the HeartBeam ECG device accurately identifies heart attack risk in c...
AI-Powered Wearables Transform Patient Monitoring and Clinical Decision-Making
Advances in artificial intelligence and edge computing are turning health care wearables into powerful clinical tools that deliver real-time, actionab...
HeartBeam’s Portable ECG Device Shows Promise in Identifying Heart Attack Risk
A peer-reviewed study published in JACC: Advances demonstrates that a risk prediction algorithm using HeartBeam’s credit card-sized ECG device can acc...
LataMed AI Corp. to Attend MEDICA 2026 in Germany as Part of Healthcare Technology Strategy
LataMed AI Corp. announces its attendance at MEDICA 2026 in Germany to evaluate emerging healthcare technologies and advance its digital health platfo...
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG Technology
HeartBeam is developing a cable-free, high-fidelity ECG platform that generates synthesized 12-lead signals from a portable device to address pre-hosp...
Smart Wristband May Detect Cardiac Arrest, Study Suggests
A small study found that a smart wristband using photoplethysmography accurately detected cardiac arrest 92% of the time, potentially enabling faster ...
American Heart Association Launches Initiative to Close Technology Gaps in Cardiac and Stroke Emergency Response
The American Heart Association, supported by T-Mobile, will convene EMS leaders in 13 U.S. cities to identify and address communication and technology...
LogicMark's AI-Driven Safety Ecosystem Redefines Aging in Place
LogicMark's evolving suite of personal emergency response systems, powered by AI and digital twin technology, transforms elder care from reactive to p...
HeartBeam Reports First-Quarter 2026 Results and Advances Commercial Launch of Cardiac Monitoring Platform
HeartBeam (BEAT) reported first-quarter 2026 results showing improved net loss of $4.7 million and progress in commercial partnerships, heart attack d...
MindBio Therapeutics Featured in BioMedWire Editorial on Real-Time Intoxication Detection Technologies
MindBio Therapeutics' AI-driven voice analysis platform for detecting impairment from speech recordings is highlighted in a BioMedWire editorial, unde...
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
SS Innovations successfully performed a telesurgery spanning over 4,500 miles using its SSi Mantra surgical robotic system, showcasing the potential t...
MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology
MindBio Therapeutics announced the development of AI-powered fatigue recognition technology for its Edge AI Intoxication Detection Kiosks, targeting h...
Voice Analysis and AI Could Revolutionize Intoxication Detection, Says MindBio Therapeutics
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication from short speech samples, offering a ...
MindBio Therapeutics Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
MindBio Therapeutics is developing an AI-driven voice analysis platform for real-time drug and alcohol intoxication detection, targeting workplace saf...
Aclarion Grants Inducement Stock Option to New Commercial Director for Western U.S. Expansion
Aclarion awarded an inducement stock option to Daniel Keefe, its new Commercial Director for the Western U.S., reflecting increased demand for its Noc...
HeartBeam Inc. Advances ECG Technology to Address Cardiovascular Disease Crisis
HeartBeam Inc. is developing next-generation ECG solutions to reduce patient delay in seeking care for heart disease, which remains the leading cause ...
Ventripoint to Showcase VMS+™ at AEPC Annual Meeting, Highlighting AI-Powered Cardiac Imaging for Congenital Heart Disease
Ventripoint Diagnostics will exhibit at the 59th AEPC meeting in Padua, Italy, emphasizing the role of its VMS+™ 4.0 system in providing MRI-equivalen...
Aclarion Reports 196% Annual Scan Volume Growth in Q1 2026, Highlighting Accelerating Clinical Adoption of Nociscan
Aclarion's Q1 2026 results show a 196% year-over-year increase in Nociscan scan volumes, driven by growing clinical adoption and strong execution, pos...
Ventripoint's VMS+ 4.0 Submitted for Regulatory Approval in China via Expedited Green Channel
Ventripoint Diagnostics and its partner Lishman Global have submitted the VMS+ 4.0 system for NMPA approval in China, with a green channel designation...
Aclarion Appoints Daniel Keefe as Commercial Director to Drive Nociscan Adoption in Western U.S.
Aclarion hires Daniel Keefe to lead Western U.S. commercial efforts, aiming to accelerate adoption of its AI-powered Nociscan platform for chronic low...
HeartBeam Collaborates with Mount Sinai to Advance AI-Driven ECG Technology
HeartBeam (NASDAQ: BEAT) is collaborating with Mount Sinai to develop AI-based ECG algorithms for remote monitoring, highlighting the shift toward dat...
Cardio Diagnostics' AI Platform Transforms Cardiovascular Risk Assessment with Precision Medicine
Cardio Diagnostics Holdings (NASDAQ: CDIO) leverages artificial intelligence to integrate multi-omic data from a blood draw, offering personalized car...
HeartBeam and Mount Sinai Collaborate to Advance AI-Driven ECG Technology
HeartBeam Inc. partners with Mount Sinai to develop and validate AI-based ECG algorithms, aiming to enhance remote cardiac monitoring and chronic cond...
SS Innovations Unveils Drone, Humanoid, and Mobile OR Robotic Systems at SMRSC 2026
SS Innovations showcased advanced surgical robotic technologies including a drone system for battlefield surgery, a humanoid surgical platform, and a ...
Why Cardio Diagnostics Holdings (CDIO) Is a Key Player in Precision Cardiovascular Medicine
Cardio Diagnostics Holdings uses AI and epigenetics to revolutionize cardiovascular disease prevention and management, making it a company to watch.
HeartBeam Closes $10M Public Offering to Advance Cardiac Technology Commercialization
HeartBeam announced the closing of a $10 million public offering to fund commercialization of its FDA-cleared 12-lead synthesized ECG system, extended...
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Leverages AI and Epigenetics to Transform Cardiovascular Care
Cardio Diagnostics Holdings is highlighted as a company to watch for its AI-powered precision medicine approach to cardiovascular disease prevention, ...
HeartBeam Closes $10 Million Public Offering to Advance Cardiac Technology Commercialization
HeartBeam Inc. raised $10 million in a public offering to fund commercialization of its FDA-cleared 12-lead synthesized ECG system and expand AI capab...
Aclarion Secures U.S. Patent for AI-Driven Chronic Low Back Pain Assessment
Aclarion received a U.S. patent covering machine learning models for analyzing MRS data to identify pain biomarkers, bolstering its Nociscan platform ...
Aclarion Receives Diamond Pinnacle Award for AI Innovation in Chronic Low Back Pain
Aclarion's Nociscan platform, which uses AI and MR spectroscopy to identify pain-causing discs, earns a Diamond Pinnacle Award for Clinical Decision A...
Catalyst Crew Technologies Unveils PulmoAI, an AI Platform for Lung Disease Detection
Catalyst Crew Technologies Corp. announced PulmoAI, an AI-driven module for detecting and predicting pulmonary diseases, aiming to improve respiratory...
Aclarion Reports Nearly 100 Nociscan Procedures at The London Clinic, Releases Physician Video
Aclarion announces growing adoption of its Nociscan technology at The London Clinic, with nearly 100 procedures performed, and releases a video featur...
TibaRay Launches Wefunder Campaign to Advance FLASH Radiotherapy Technology
TibaRay opens its Regulation CF campaign on Wefunder, allowing individual investors to support the development of its next-generation accelerator tech...
HeartBeam Inc.'s FDA Clearance and Analyst Upgrade Signal Shift to Commercial Stage
HeartBeam Inc. received FDA clearance for its 12-lead ECG synthesis software, leading to an analyst upgrade and price target increase, marking a pivot...
CardioDialysis: A Next-Generation Blood Purification Device Could Revolutionize Cardiovascular Disease Treatment
Sigyn Therapeutics' CardioDialysis, a single-component device deployable on existing dialysis machines, aims to reduce major adverse cardiovascular ev...
HeartBeam Partners With Mount Sinai to Accelerate AI-ECG Development and Validation
HeartBeam (NASDAQ: BEAT) announced a collaboration with Mount Sinai to develop and validate AI-based ECG algorithms for wellness and clinical applicat...
NextPlat Corp. Schedules Full-Year 2025 Earnings Release and Conference Call for March 31
NextPlat Corp. will release its full-year 2025 financial results on March 31, 2026, followed by a conference call to review performance and discuss de...
Catalyst Crew Technologies Seeks FINRA Approval for Name and Symbol Change to LataMed AI Corp.
Catalyst Crew Technologies has submitted a request to FINRA to change its name to LataMed AI Corp. and its trading symbol, reflecting its strategic pi...
Aclarion Adopts Limited Duration Stockholder Rights Plan to Protect Long-Term Value
Aclarion's board unanimously adopted a one-year stockholder rights plan to prevent any person or group from gaining control without paying a fair prem...
Aclarion CEO Letter Highlights Reimbursement Progress and 2026 Catalysts for Nociscan Platform
Aclarion's CEO shareholder letter outlines key 2026 priorities including pursuing U.S. insurance reimbursement, initial CLARITY trial readout in Q4 20...
SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines, Surpasses 150 Cumulative Procedures
SS Innovations announces regulatory approval for telesurgeries using its SSi Mantra system in Indonesia and the Philippines, and surpasses 150 cumulat...
NeuroOne Announces Publication of Clinical Experience With OneRF sEEG-Guided Radiofrequency Ablation Technology
NeuroOne's OneRF Ablation System, the first FDA-cleared system allowing nervous tissue ablation through the same sEEG electrode used for diagnostics, ...